30 Day Trial

Hyalex Orthopaedics Increases Series A Total to $33MM

Hyalex Orthopaedics, developer of HYALEX™ synthetic polymer that is designed to mimic hyaline cartilage, grew its original Series A funding to US $33MM. 

Alphatec Launches IdentiTi Porous Titanium Interbody Cage

Alphatec announced commercial release of the IdentiTi-C Porous Titanium Interbody for ACDF.

MiRus Gains FDA Clearance for Molybdenum Rhenium Pedicle Screw

MiRus received FDA 510(k) clearance for the Europa™ pedicle screw made of MoRe® molybdenum rhenium superalloy material.

Exactech's First Hip Procedure with Alteon Cup and XLE Liner

Exactech announced the successful first hip replacement with the Alteon® Cup and XLE® Liner.

Bioventus Launches OSTEOAMP SELECT Fibers

Bioventus introduced OSTEOAMP® SELECT Fiber allograft bone graft substitute for spine, foot/ankle, orthopedic and trauma procedures.

SpineEX Receives Additional FDA Clearance for Sagittae LLIF

SpineEX gained additional FDA clearance for the Sagittae Lateral Lumbar Interbody Fusion system, covering new instrumentation and an updated surgical technique.

Zimmer Biomet Gains FDA Clearance of ROSA ONE Spine System for Robotically-Assisted Surgeries

Zimmer Biomet received FDA 510(k) clearance to market the ROSA® ONE Spine System for robotically-assisted spine procedures.

Bone Biologics Receives Approval for Trial of NB1 Growth Factor in Australia

Bone Biologics received regulatory approval in Australia for a multicenter pilot clinical trial to evaluate NELL-1/DBX® in the treatment of degenerative disc disease.

Graftys Completes Capital Raise for Expansion

Graftys completed a €4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute.

Seikagaku Launches HyLink in Italy

Seikagaku commenced Italy launch of HyLink® single-injection viscosupplement for knee osteoarthritis.

 



It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this pageStill have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via 
email.

Read more from ORTHOWORLD: